Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 70

Cited In for PubMed (Select 7874169)


Closing the Gap: Genetic and Genomic Continuum from Syndromic to Nonsyndromic Craniosynostoses.

Heuzé Y, Holmes G, Peter I, Richtsmeier JT, Jabs EW.

Curr Genet Med Rep. 2014 Sep 1;2(3):135-145.


The Fibroblast Growth Factor signaling pathway.

Ornitz DM, Itoh N.

Wiley Interdiscip Rev Dev Biol. 2015 May-Jun;4(3):215-66. doi: 10.1002/wdev.176. Epub 2015 Mar 13.


FGFR1 signaling in hypertrophic chondrocytes is attenuated by the Ras-GAP neurofibromin during endochondral bone formation.

Karolak MR, Yang X, Elefteriou F.

Hum Mol Genet. 2015 May 1;24(9):2552-64. doi: 10.1093/hmg/ddv019. Epub 2015 Jan 23.


Pfeiffer syndrome: clinical and genetic findings in five Brazilian families.

Júnior HM, de Aquino SN, Machado RA, Leão LL, Coletta RD, Burle-Aguiar MJ.

Med Oral Patol Oral Cir Bucal. 2015 Jan 1;20(1):e52-8.


Mutational identification of fibroblast growth factor receptor 1 and fibroblast growth factor receptor 2 genes in craniosynostosis in Indian population.

Pandey RK, Bajpai M, Ali A, Gayan S, Singh A.

Indian J Hum Genet. 2013 Oct;19(4):449-53. doi: 10.4103/0971-6866.124374.


Molecular Analysis of Twist1 and FGF Receptors in a Rabbit Model of Craniosynostosis: Likely Exclusion as the Loci of Origin.

Gallo PH, Cray JJ Jr, Durham EL, Mooney MP, Cooper GM, Kathju S.

Int J Genomics. 2013;2013:305971. doi: 10.1155/2013/305971. Epub 2013 May 8.


Syndromic craniosynostosis.

Derderian C, Seaward J.

Semin Plast Surg. 2012 May;26(2):64-75. doi: 10.1055/s-0032-1320064.


The ras-GTPase activity of neurofibromin restrains ERK-dependent FGFR signaling during endochondral bone formation.

Ono K, Karolak MR, Ndong Jde L, Wang W, Yang X, Elefteriou F.

Hum Mol Genet. 2013 Aug 1;22(15):3048-62. doi: 10.1093/hmg/ddt162. Epub 2013 Apr 9.


The fibroblast growth factor receptor 2 p.Ala172Phe mutation in Pfeiffer syndrome--history repeating itself.

Jay S, Wiberg A, Swan M, Lester T, Williams LJ, Taylor IB, Johnson D, Wilkie AO.

Am J Med Genet A. 2013 May;161A(5):1158-63. doi: 10.1002/ajmg.a.35842. Epub 2013 Mar 26.


The genetic basis of female reproductive disorders: etiology and clinical testing.

Layman LC.

Mol Cell Endocrinol. 2013 May 6;370(1-2):138-48. doi: 10.1016/j.mce.2013.02.016. Epub 2013 Mar 14. Review.


Talocalcaneal coalition in Muenke syndrome: report of a patient, review of the literature in FGFR-related craniosynostoses, and consideration of mechanism.

Agochukwu NB, Solomon BD, Benson LJ, Muenke M.

Am J Med Genet A. 2013 Mar;161A(3):453-60. doi: 10.1002/ajmg.a.35233. Epub 2013 Feb 1. Review.


Runx2 protein represses Axin2 expression in osteoblasts and is required for craniosynostosis in Axin2-deficient mice.

McGee-Lawrence ME, Li X, Bledsoe KL, Wu H, Hawse JR, Subramaniam M, Razidlo DF, Stensgard BA, Stein GS, van Wijnen AJ, Lian JB, Hsu W, Westendorf JJ.

J Biol Chem. 2013 Feb 22;288(8):5291-302. doi: 10.1074/jbc.M112.414995. Epub 2013 Jan 7.


Craniosynostosis: molecular pathways and future pharmacologic therapy.

Senarath-Yapa K, Chung MT, McArdle A, Wong VW, Quarto N, Longaker MT, Wan DC.

Organogenesis. 2012 Oct-Dec;8(4):103-13. doi: 10.4161/org.23307. Epub 2012 Oct 1. Review.


Craniofacial surgery, from past pioneers to future promise.

Wan DC, Kwan MD, Kumar A, Bradley JP, Longaker MT.

J Maxillofac Oral Surg. 2009 Dec;8(4):348-56. doi: 10.1007/s12663-009-0084-x. Epub 2010 Apr 24.


Impact of genetics on the diagnosis and clinical management of syndromic craniosynostoses.

Agochukwu NB, Solomon BD, Muenke M.

Childs Nerv Syst. 2012 Sep;28(9):1447-63. doi: 10.1007/s00381-012-1756-2. Epub 2012 Aug 8. Review.


The epidemiology, genetics and future management of syndactyly.

Jordan D, Hindocha S, Dhital M, Saleh M, Khan W.

Open Orthop J. 2012;6:14-27. doi: 10.2174/1874325001206010014. Epub 2012 Mar 23.


Role of fibroblast growth factor (FGF) signaling in the neuroendocrine control of human reproduction.

Miraoui H, Dwyer A, Pitteloud N.

Mol Cell Endocrinol. 2011 Oct 22;346(1-2):37-43. doi: 10.1016/j.mce.2011.05.042. Epub 2011 Jun 1. Review.


Conditional ablation of Pten in osteoprogenitors stimulates FGF signaling.

Guntur AR, Reinhold MI, Cuellar J Jr, Naski MC.

Development. 2011 Apr;138(7):1433-44. doi: 10.1242/dev.058016.


Targeting mutant fibroblast growth factor receptors in cancer.

Greulich H, Pollock PM.

Trends Mol Med. 2011 May;17(5):283-92. doi: 10.1016/j.molmed.2011.01.012. Epub 2011 Mar 1. Review.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk